Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7342 p362
26 March 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Council election
· The profession (5)
· Community pharmacy (3)
· Revalidation
· The Society
· Prescription charges


Letters to the Editor

The Society

A nonsense of the whole thing …

From Mr W. B. Rhodes, FRPharmS

I am surprised that Stephen Axon (PJ, 12 March, p300), with his legal training, should have the effrontery to delete the whole declaration relating to his supposed non-practising status from his annual retention fee form and expect to remain on the Register.

I being of a more timid disposition only deleted the section to which I took particular exception and I know of others who similarly deleted phrases, albeit not the same as mine. So far as I am aware my application was accepted, although the letter I received simply stated that I had “tendered my fee” not that it had been accepted, but as I have not received the statutory notice I presume I am still on the Register.

If the Royal Pharmaceutical Society has accepted a variety of declarations, or in the case of Stephen Axon none at all, this makes a nonsense of the whole thing. It follows that we should know just what our status is and the declaration be sensibly redrafted allowing the opportunity for those who felt that they could not in all conscience remain on the Register with such restrictions to return to the fold.

Bruce Rhodes
Cheltenham, Gloucestershire

 

ANN LEWIS, Secretary and Registrar, Royal Pharmaceutical Society, states:

The retention fee cycle for 2005 will be completed on the 5 April. At that time the Society will examine all circumstances in which declaration requirements have not been fulfilled and decisions will be taken as to appropriate next steps. Individuals who have failed to comply with the declaration requirements will be contacted at the earliest opportunity after the retention fee cycle completion date.

Send your letter to The Editor

Previous Topic (Revalidation)
Next Topic (Prescription charges)

Back to Top


©The Pharmaceutical Journal